(6-089) Efficacy of Andexanet Alfa Compared to Prothrombin Complex Concentrate in Reversing Coagulopathy in Patients with Life-threatening Hemorrhage While on Factor Xa Inhibitors
Tuesday, December 6, 2022
10:45 AM – 11:45 AM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Critical Care
Co-Author(s): Jaron Lakey, Jordan Penrod, David Peters
